9/20 #TumorBoardTuesday

💡Mini tweetorial 5

📚STAMPEDE (Arm H) trial
ADT vs ADT + radiotherapy to primary
Prespecified low and high burden of disease groups
High burden: no OS difference
Low burden OS at 3 years: 73% w/o RT vs 81% w/ RT
#TumorBoardTuesday